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38036 | RSC Adv., 2018, 8, 38036–380d-type caseinate glycation on the
preventive action of caseinate digests in
acrylamide-induced intestinal barrier dysfunction
in IEC-6 cells
Jia Shi,a Yu Fub and Xin-Huai Zhao *a
Dietary acrylamide has attracted widespread concern due to its toxic eﬀects; however, its adverse impact on
the intestines is less assessed. Protein glycation of the Maillard-type is widely used for property modiﬁcation,
but its potential eﬀect on preventive eﬃcacy of protein digest against the acrylamide-induced intestinal barrier
dysfunction is quite unknown. Caseinate was thus glycated with lactose. Two tryptic digests from the glycated
caseinate and untreated caseinate (namely GCN digest and CN digest) were then assessed for their protective
eﬀects against acrylamide-induced intestinal barrier dysfunction in the IEC-6 cell model. The results showed
that acrylamide at 1.25–10 mmol L1 dose-dependently had cytotoxic eﬀects on IEC-6 cells, leading to
decreased cell viability and increased lactate dehydrogenase release. Acrylamide also brought about barrier
dysfunction, including decreased trans-epithelial electrical resistance (TEER) value and increased epithelial
permeability. However, the two digests at 12.5–100 mg mL1 could alleviate this dysfunction via enhancing
cell viability by 70.2–83.9%, partly restoring TEER values, and decreasing epithelial permeability from 100%
to 76.6–94.1%. The two digests at 25 mg mL1 strengthened the tight junctions via increasing tight junction
proteins ZO-1, occludin, and claudin-1 expression by 11.5–68.6%. However, the results also suggested that
the GCN digest always showed lower protective eﬃcacy than the CN digest in the cells. It is concluded
that Maillard-type caseinate glycation with lactose endows the resultant tryptic digest with impaired
preventive eﬀect against acrylamide-induced intestinal barrier dysfunction, highlighting another adverse
eﬀect of the Maillard reaction on food proteins.Introduction
Acrylamide, a water-soluble vinyl monomer, can be produced
during high-temperature food processing, and has several toxic
eﬀects in the body.1 In general, acrylamide as a dietary toxicant
can cause neurotoxicity, genotoxicity, reproductive toxicity, and
even carcinogenicity in both animals and humans. The
acrylamide-induced cytotoxicity usually occurs via oxidative
stress.2,3 Acrylamide from the diet can be rapidly absorbed to
a high degree in the intestines and then converted into epoxide
glycidamide.4,5 It is evident that the maternal acrylamide has
a negative eﬀect on the small intestine histomorphometry of
guinea pig oﬀspring,6 and can increase the numbers of total,
divided, inactive crypts, and damaged villi in the duodenum
and jejunum.7 Intestinal absorptive surface can also be aﬀected
by acrylamide in the jejunum.6 Thus, potential harmful eﬀects
of acrylamide on the body health can not be ignored. Twory of Education, Northeast Agricultural
ail: zhaoxh@neau.edu.cn; xhzhao63@
86 451 55191813
f Science, University of Copenhagen,
46previous studies had shown that acrylamide could induce the
loss of tight junction (TJ) integrity, leading to intestinal barrier
dysfunction with subsequent translocation of luminal
substances (such as bacterial endotoxins) into the portal
circulation and consequently intestinal injury.8,9
Intestinal barrier function is closely related to intestinal
health and disease prevention. Intestinal epithelial cells serve
as the rst line of defense against pathogens, and play an
important role in the maintenance of gut barrier function.10
Intestinal transport and barrier function are established by
a layer of epithelial cells. These cells are linked together by the
TJ strands, which govern epithelial permeability and integ-
rity.11,12 Intestinal mucosal integrity and permeability are regu-
lated by physiological and environmental factors, such as heat
stress and other physical stressors, pathogenic microorgan-
isms, age, and dietary factors.13,14 Barrier function of the intes-
tine is highly regulated by TJ proteins, allowing the epithelium
to control the transmucosal permeability to water, electrolytes,
and smaller solutes. Among these TJ proteins are occludin,
junction adhesion molecule A, claudins, and zonula occludens
proteins (ZO-1 and ZO-2), which connect adjacent cells and
build the intestinal barrier.15 TJ defects implicate theThis journal is © The Royal Society of Chemistry 2018
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View Article Onlinepathogenesis of a number of intestinal diseases like sepsis,
inammatory bowel disease, and bacteria-induced diarrhea.16,17
Barrier defects in disease pathogenesis result from the altered
expression of TJ proteins.18 Claudins are the main proteins
regulating TJ functions.19 Occludin (the rst identied trans-
membrane TJ protein) plays a critical role in maintaining TJ
barrier function.20 Occludin as an invariant component is
expressed in almost epithelial TJ structures.21 Zonula occlu-
dens, a belt-like region to contact the polarized epithelial cells,
behave as a selective barrier to the small molecules but a total
barrier to the large molecules.22 ZO-1 is a structural and func-
tional marker of epithelial TJs.23 These TJ proteins are thus
widely assessed to reect epithelial barrier function.
Milk proteins upon digestion will generate numerous
peptides with various biofunctions.24,25 Bioactive peptides are
usually prepared with various proteases, including gastroin-
testinal enzymes (pepsin and trypsin). In general, both amino
acid compositions and sequences are important to the activities
of bioactive peptides (or protein hydrolysates).26 During milk
processing, the caseins are susceptive to the Maillard reaction
and thus can be glycated with lactose. Maillard-type protein
glycation enhances functional properties of the proteins.27
However, it is well-known that the Maillard reaction has some
negative impacts on both nutrition and quality of the processed
foods due to the formation of undesired colour and avor
products and especially toxic/mutagenic compounds, together
with partially reduced bioavailability of the essential amino
acids.28,29 Moreover, there is an increasing trend in the
consumption of the processed food around the world. The
intake and absorption of the Maillard reaction products (espe-
cially the advanced glycation end-products, AGEs) thus deserves
special attention, because dietary AGEs intake is unavoidable
and AGEs can act as seeds for the in vivo formation of other
products.30 To the best of our knowledge, very few data are
available on the eﬀects of casein glycation on native caseins or
casein digests activities, so its study deserves consideration in
scientic community.
Some luminal factors including food components can aﬀect
barrier function of the intestinal epithelium via TJ modulation.
Beta-casofensin generated from bovine b-casein has a preven-
tive eﬀect against the indomethacin-induced intestinal lesions,
and thus preserves goblet cells and improves wound healing.31
Other components such as oligosaccharides, oxyresveratrol,
quercetin, and resveratrol also have a similar protective
eﬀect.32–35 This study thus assessed and compared the protective
eﬃcacy of two tryptic caseinate digests against the acrylamide-
induced epithelial barrier dysfunction in a cell model (rat
small intestine epithelium IEC-6 cells) via evaluating intestinal
epithelial integrity and intercellular TJ protein expression. One
tryptic caseinate digest (namely CN digest) was yielded from
commercial caseinate and served as control. Another digest
(namely GCN digest) was generated from a lactose-glycated
caseinate of the Maillard-type. This study aimed to provide
a novel insight into the Maillard-type protein glycation, veri-
fying if this reaction might confer tryptic digest with changed
protective eﬃcacy against the induced epithelial barrier
dysfunction.This journal is © The Royal Society of Chemistry 2018Materials and methods
Materials
Caseinate (protein content of 984.2 g kg1 on dry basis), D-
lactose, acrylamide (purity > 99%), bovine insulin, four kilo
dalton uorescein isothiocyanate-dextran (FD-4), bovine serum
albumin (BSA), and Dulbecco's modied Eagle's medium
(DMEM) were purchased from Sigma-Aldrich Co. (St. Louis,
MO, USA). Phosphate-buﬀered saline (PBS) was bought from
Solarbio Science and Technology Co. Ltd. (Beijing, China).
Trypsin (EC 3.4.21.4) with an activity of 120 kU per gram was
purchased from Beijing Aoboxing Biotechnologies Inc. (Beijing,
China). Fetal bovine serum was obtained from Wisent Inc.
(Montreal, Quebec, Canada). EnzycChrom™ Galactose Assay
Kit was purchased from BioAssay Systems (Hayward, CA, USA).
Cell counting kit-8 (CCK-8) was bought from Dojindo Molecular
Technologies, Inc. (Kyushu, Japan). Lactate dehydrogenase
(LDH) kit was bought from Nanjing Jiancheng Bioengineering
Institute (Nanjing, Jiangsu, China). Protein extraction kit was
purchased from Beyotime Institute of Biotechnology (Shanghai,
China). RNAprep pure Cell/Bacteria kit was purchased from
Tiangen Biotech Co. Ltd. (Beijing, China). PrimeScript™ RT
reagent Kit and SYBR® Premix Ex Taq™ (Tli RNaseH Plus) were
purchased from Takara Bio Inc. (Kusatsu, Japan). Primary
antibodies (GAPDH ab181602, occludin ab216327, claudin-1
ab15098) were purchased from Abcam plc. (Cambridge, UK).
ZO-1 (AF5145) was purchased from Aﬃnity Biosciences (Cin-
cinnati, OH, USA). Goat anti-rabbit secondary antibody was
purchased from Bioss Biotechnology Co., Ltd. (Beijing, China).
Sample preparation
The lactose-glycated caseinate was prepared as previously
described.36 Briey, the reaction mixture (pH 6.7) was prepared
with caseinate (50 g L1) and lactose (80 g L1), heated at a water
bath (100 C) for 3 h with constant stirring, rapidly cooled with an
ice bath to stop the reaction, subjected to isoelectric precipitation
followed by three isoelectric washings (pH 4.5) to remove free
lactose, and then freeze-dried to obtain the glycated caseinate.
Both the glycated caseinate and caseinate (50 g L1) were
dispersed in water at pH 7.0, hydrolyzed with trypsin (7 kU g1
protein) for 4 h at 37 C, heated at a boiling bath for 5 min to
inactivate trypsin, cooled rapidly to 20 C, adjusted to pH 7.0
with 0.5 mol L1 NaOH, and then centrifuged at 5000  g for
20 min to obtain the corresponding GCN digest and CN digest,
which were also freeze-dried.
Chemical analyses
Protein content was assessed using the Kjeldahl method and
a conversion factor of 6.38.37 Aer then, both the glycated
caseinate and GCN digest were hydrolyzed with 2 mol L1 tri-
uoroacetic acid at 100 C for 4 h, cooled to 20 C, and
neutralized into pH 7.0 with 0.5 mol L1 NaOH. The obtained
hydrolysates were detected for galactose contents using the
Galactose Assay Kit and procedure provided by the kit producer.
Lactose contents (g kg1 protein) of the samples were thereby
calculated chemically.RSC Adv., 2018, 8, 38036–38046 | 38037
Table 1 Primer sequences for TJ proteins and GAPDH
Genes Primers (50–30) Product lengths (bp)
ZO-1 (mouse) For AGCTGCCTCGAACCTCTACTCTAC 176
Rev GCCTGGTGGTGGAACTTGCTC
ZO-2 (mouse) For GATAGCAGCCATCGTGGTCAAGAG 153
Rev TGCCGACTCCTCTCACTGTAGC
Occludin (mouse) For TGGCTATGGAGGCGGCTATGG 114
Rev AAGGAAGCGATGAAGCAGAAGGC
Claudin-1 (mouse) For GGTGCCTGGAAGATGATGAGGTG 91
Rev GCCACTAATGTCGCCAGACCTG
Claudin-3 (mouse) For GTCGGCCAACACCATCATCAGG 143
Rev GGCAGGAGCAACACAGCAAGG
Claudin-4 (mouse) For TTCATCGGCAGCAACATCGTCAC 113
Rev GCGAGCATCGAGTCGTACATCTTG
GAPDH For GGTTGTCTCCTGCGACTTCA 183
Rev TGGTCCAGGGTTTCTTACTCC
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View Article OnlineCell line and culture conditions
IEC-6 cells were bought from the American Type Culture
Collection (Rockville, MD, US), and cultured in the DMEM
containing 10% fetal bovine serum, 1% sodium pyruvate, and
0.1 units per mL bovine insulin. As recommended by the cell
provider, IEC-6 cells were grown in a humidied 37 C incu-
bator with 5% CO2.Cytotoxicity assay
Cytotoxicity was measured by the CCK-8 assay according to the
instructions of kit manufacturer. IEC-6 cells (3  103 cells per
well) were seeded in 96-well plates for 24 h prior to the assay,
serum-starved for 12 h, and incubated with acrylamide (0, 1.25,
2.5, 5, and 10 mmol L1) contained in fresh medium. The cells
were further incubated for 24 h. 100 mL of 10% CCK-8 solution
were added to each well, and the cells were incubated for 1.5 h.
Optical density values were measured at 450 nm on amicroplate
reader (Bio-Rad Laboratories, Hercules, CA, USA).Cell viability assay
Cell viability was also measured by the CCK-8 assay. In brief,
IEC-6 cells (3  103 cells per well) were plated on 96-well plates
to conuence for 24 h, starved for 12 h, and incubated with
fresh medium added or not with the two digests for a nal
concentration of 12.5–100 mgmL1. The cells were incubated for
24 and 48 h, and then incubated with 2.5 mmol L1 acrylamide
for 24 h. 100 mL of 10% CCK-8 solution were added into each
well, and the cells were incubated for 1.5 h. OD values at 450 nm
was read by the microplate reader, and used to calculate cell
viability (%). The cells received the medium only served as
control cells with a designated viability value of 100%.Fig. 1 Cytotoxicity (%) of acrylamide (1.25–10mmol L1) to IEC-6 cells
with treatment time of 24 h. Diﬀerent letters above the columns
indicate that the mean values diﬀer signiﬁcantly (p < 0.05).Trans-epithelial electrical resistance assay
Trans-epithelial electrical resistance (TEER) is a common
integrity indicator of cell monolayers. TEER value of the cells
was measured as previously described.38 IEC-6 cells were grown
on the Transwell inserts (12 mm diameter, 0.4 mm pore size,
polyester membranes, Corning) in 12-well plates (2  105 cells38038 | RSC Adv., 2018, 8, 38036–38046per well) until the TEER value reached to 50 U cm2, and then
treated in the serum-free medium for 12 h. Fresh medium with
or without the two digests at a nal concentration ranging 12.5–
100 mg mL1 was added into the apical transwell compartment
for 12, 24, and 48 h. The cells were further incubated with
2.5 mmol L1 acrylamide for 24 h. TEER was measured by the
Millicell-ERS2 Volt-Ohm Meter (Millipore, Bedford, MA, USA).
Resistance values were recorded and calculated as U cm2 by
multiplying the membrane lter area, and expressed as
percentage as % TEER ¼ (TEERtreatment/TEERcontrol)  100%.Measurement of lactate dehydrogenase release
LDH release into the culture medium is a cell injury indicator,
and thus was measured to evaluate cell death. IEC-6 cells (3 
103 cells per well) were seeded in 96-well plates to conuence forThis journal is © The Royal Society of Chemistry 2018
Fig. 2 Viability values (%) of IEC-6 cells treated with two digests for 24
(a) or 48 h (b) and then treated with 2.5 mmol L1 acrylamide for 24 h.
The statistical treatment was done comparing concentrations of
diﬀerent digests. Diﬀerent letters above the columns indicate that the
mean values diﬀer signiﬁcantly (p < 0.05).
Fig. 3 LDH release in IEC-6 cells treated with two digests for 24 (a)
and 48 h (b) and then treated with 2.5 mmol L1 acrylamide for 24 h.
The statistical treatment was done comparing concentrations of
diﬀerent digests. Diﬀerent letters above the columns indicate that the
mean values diﬀer signiﬁcantly (p < 0.05).
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View Article Online24 h, starved for 12 h and incubated with fresh medium with or
without the two digests at a nal concentration ranging 12.5–
100 mg mL1 for 24 and 48 h. The cells were further incubated
with 2.5 mmol L1 acrylamide for 24 h, and centrifuged at 190
g for 5 min. The collected supernatants were measured for LDH
release using the lactate dehydrogenase assay kit and kit
protocol. The cells received themedium only were designated as
control cells with LDH release value of 100%.This journal is © The Royal Society of Chemistry 2018Assay of paracellular permeability
Epithelial permeability across IEC-6 cells was assessed by
judging the passage of 4 kDa uorescein isothiocyanate (FITC)-
dextran from the apical to basolateral chambers of the Trans-
well permeable support inserts. Briey, IEC-6 cells (2 105 cells
per well) were grown in 0.4 mmpore inserts, treated with the two
digests (25 mg mL1) for 24 and 48 h, and further incubated withRSC Adv., 2018, 8, 38036–38046 | 38039
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View Article Online2.5 mmol L1 acrylamide for 24 h as described previously.32 The
4 kDa uorescein isothiocyanate (FITC)-dextran was dissolved
in the medium and used at nal concentration of 0.5 mg mL1
in the apical cell compartment. Aer 24 h of incubation, uo-
rescence was measured in the basal compartment using a uo-
rescent microplate reader (Innite M200 pro, TECAN,
Ma¨nnedorf, Switzerland) at respective excitation and emission
wavelengths of 490 and 520 nm. Fluorescence levels were
recorded as relative uorescence units (RFU). Results were
expressed as percentages of control value: % cumulative ux of
4 kDa FITC-dextran (FD-4) ¼ (RFUtreatment/RFUcontrol)  100%.Immuno-uorescence assay
Immuno-uorescence image assay was used to verify the locali-
zation and production of TJ-associated ZO-1, occludin, and
claudin-1 approximately. IEC-6 cells (about 1  104 cells) were
seeded on the coverslips (15 mm diameter, 0.13–0.16 mm
thickness), treated with the two digests (25 mg mL1) for 24 and
48 h, and further incubated with 2.5 mmol L1 acrylamide for
24 h as described previously.39 Aer these treatments, IEC-6 cells
were washed twice with PBS (0.1 mol L1, pH 7.2), xed with 4%
formaldehyde in the PBS for 10min, and permeabilized for 5min
at 20 C using 0.2% Triton X-100 in the PBS. The cells were
blocked with 5% BSA in the PBS for 1 h at 20 C, and incubated at
4 C overnight with the primary antibodies anti-ZO-1, anti-
occludin, and anti-claudin-1 (1 : 100 dilution by 5% BSA), fol-
lowed by the biotinylated secondary antibody incubation 90 min
and DAPI counterstaining. The TJ proteins were observed by an
OLYMPUS IX71 uorescence microscope (Olympus Corp., Tokyo,
Japan) to obtain respective images.Quantitative real-time PCR assay
The mRNA levels of the TJ genes of IEC-6 cells were character-
ized by quantitative real-time PCR. IEC-6 cells were treated withFig. 4 Time-responses of TEER in IEC-6 cells treated with two digests fo
are expressed as percentage of TEER relative to the control. The statistic
Diﬀerent letters above the columns indicate that the mean values diﬀer
38040 | RSC Adv., 2018, 8, 38036–38046the two digests (25 mg mL1) for 48 h, and further incubated
with 2.5 mmol L1 acrylamide for 24 h. With the kits' guide-
lines, total RNA was isolated with the RNAprep pure Cell/
Bacteria kit, and then reversed transcribed into complemen-
tary DNA (cDNA) with the PrimeScript™ RT reagent kit. The
amplied cDNA was utilized for the template DNA and per-
formed with specic primers (Table 1) for PCR assay. The
SYBR® Premix Ex Taq™ (Tli RNaseH Plus) was used in real-time
PCR analysis performed in 96-well plates for a total 25 mL
reaction mixtures, using an Applied Biosystems StepOnePlus
Real-time PCR System (Life Technologies Corporation, Carls-
bad, CA, USA). Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was amplied as internal control. Average quanti-
cation cycle threshold (Ct) of triplicate samples was calculated
as the quantity of gene product, and the relative mRNA
expression levels were analyzed by a 2DDCt method.40 mRNA
level in each sample was quantied by converting the cycle
threshold.Western blot assay
Expression levels of TJ proteins of IEC-6 cells were determined
using the western blot assay. IEC-6 cells (1  105 cells per well)
were seeded in 6-well plates, treated with or without the two
digests (25 mg mL1) for 24 and 48 h, further incubated with
2.5 mmol L1 acrylamide for 24 h, immediately rinsed with the
ice-cold PBS, and lysed with a radio-immunoprecipitation assay
(RIPA) lysis buﬀer (Beyotime Biotechnology, Shanghai, China),
with PMSF (1 mmol L1) on ice for 30 min. Cell lysates were
centrifuged at 4 C for 5 min at 14 000  g to collect superna-
tants for protein assay using the BSA Protein Assay Kit (Beyo-
time Biotechnology). Equal protein amount (50 mg) for each
sample was separated on 10% SDS-PAGE gel (occludin and
claudin-1) or on 7.5% SDS-PAGE gel (ZO-1). Proteins from the
gel were transferred to the PVDF membrane, which werer 12–48 h and then treated with 2.5 mmol L1 acrylamide for 24 h. Data
al treatment was done comparing concentrations of diﬀerent digests.
signiﬁcantly (p < 0.05).
This journal is © The Royal Society of Chemistry 2018
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View Article Onlineblocked with 5% skimmed milk in the PBS containing 0.1%
Tween-20 for 2 h at 37 C and incubated with the primary
antibodies (1 : 1000 dilution) at 4 C overnight. The membranes
were washed three times with the PBS containing 0.1% Tween-
20, incubated with the secondary horseradish peroxidase-
conjugated antibody (1 : 1500 dilution) for 1 h at 30 C. The
enhanced chemiluminescence was covered on the membrane.
Protein bands were detected using an Amersham Imager 600
(General Electric Company, Boston, MA, USA). Quantication
was performed with Image J soware (National Institutes of
Health, Bethesda, MD, USA). The band density was normalized
to the endogenous reference GAPDH.Statistical analysis
The data from three independent experiments were reported as
mean values  standard deviations and compared using the
SPSS 16.0 soware (SPSS Inc., Chicago, IL, USA). Signicant
diﬀerences (set at p < 0.05) between the means of multiple
groups were evaluated by one-way analysis of variance (ANOVA)
with Duncan's multiple range tests.Fig. 5 Diﬀusion of FD-4 in IEC-6 cells treated with two digests for 24
(a) or 48 h (b), and then treated with 2.5 mmol L1 acrylamide for 24 h.
The statistical treatment was done comparing concentrations of
diﬀerent digests. Diﬀerent letters above the columns indicate that the
mean values diﬀer signiﬁcantly (p < 0.05).Results and discussion
Alleviated acrylamide cytotoxicity by the two digests
Lactose was in fact conjugated with caseinate in this study via
the conducted Maillard reaction, because lactose was detected
in the glycated caseinate at a concentration of 12.6 g kg1
protein. Consequently, the GCN digest was also detected to
contain lactose at 10.8 g kg1 protein. This fact meant that the
CN digest was diﬀerent from the GCN digest in this chemical
feature. In other words, the GCN digest might have a diﬀerent
eﬀect from the CN digest in IEC-6 cells.
Acrylamide showed clear cytotoxicity to IEC-6 cells, as the
obtained CCK-8 assay results indicated (Fig. 1). Acrylamide
dose-dependently reduced cell viability of the treated cells.
Exposed to 1.25, 2.5, 5, and 10 mmol L1 acrylamide for 24 h,
cell viability values decreased from 100% (the control cells) to
83%, 68%, 52%, and 25%, respectively. Acrylamide at 2.5 mmol
L1 exerted a toxic eﬀect on IEC-6 cells with decreased cell
viability of 32%, and thus was used in later evaluation to injury
the cells. Acrylamide doses other than 2.5 mmol L1 induced
lower or too higher cytotoxicity, and were no longer used in this
study.
To select eﬀective concentrations of the two digests for later
experiments, the cells were also rst treated with them and then
incubated with 2.5 mmol L1 acrylamide for 24 h. The results
(Fig. 2) showed that the CN digest and GCN digest at 12.5–100
mg mL1 resulted in cell viability values of 71.7–78.9% and 70.2–
75.3% (24 h), or 74.3–83.9% and 72.4–78.8% (48 h), respectively.
In these cases, the CN digest showed higher ability than the
GCN digest to maintain cell viability values. Further results
(Fig. 3) also indicated that 2.5 mmol L1 acrylamide injured the
cells and increased LDH release signicantly. However, pre-
treatment with the two digests decreased LDH release eﬃ-
ciently, especially when the cells were incubated for 48 h. The
two digests thus had antagonistic eﬀects (but in diﬀerentThis journal is © The Royal Society of Chemistry 2018extents) on the acrylamide-induced cell injury, leading to
increased cell viability and decreased LDH release. This fact
suggests that the Maillard-type caseinate glycation with lactose
decreased the protective activity initially present in the native
caseins.
Several chemicals such as acrylamide, indomethacin, and
deoxynivalenol are able to induce cell injury. These foods such
as roasted coﬀee and potato chips have higher acrylamideRSC Adv., 2018, 8, 38036–38046 | 38041
Fig. 6 Relative mRNA expression of TJ proteins in IEC-6 cells treated with two digests for 24 (a) or 48 h (b), and then treated with 2.5 mmol L1
acrylamide for 24 h. The statistical treatment was done comparing concentrations of diﬀerent digests. Diﬀerent letters above the columns
indicate that the mean values diﬀer signiﬁcantly (p < 0.05).
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View Article Onlineconcentrations, and the children and adolescents tend to intake
more acrylamide.6 The acrylamide-induced cytotoxicity in the
intestine thus deserves special attention. Acrylamide at 2.5 and
5 mmol L1 can induce Caco-2 and MDA-MB-231 cells injury
with decreased cell viability.5,41 However, some compounds can
ameliorate cell injury. Hispidin from the edible fungus Phellinus
linteus can increase viability of the acrylamide-injured Caco-2
cells.5 Resveratrol is non-toxic to IPEC-J2 cells but can protect
against the deoxynivalenol-induced cell damage.31 Cyanidin-3-
glucoside is capable of protecting against the acrylamide-
induced oxidative stress in MDA-MB-231 cells, provoking
enhanced cell viability and decreased LDH release.41 It is thus
reasonable that acrylamide could also induce IEC-6 cells injury,
whilst the two digests gave preventive activities to alleviate this
induced cell injury. Cell pre-treatment with the two digests
brought about diﬀerent preventive eﬃcacies, which might38042 | RSC Adv., 2018, 8, 38036–38046mainly arise from the conducted Maillard-type caseinate
glycation.
Eﬀects of the two digests on TEER and paracellular
permeability
To determine if the two digests could protect cell monolayers
from the acrylamide-induced permeability injury, TEER assay
was thus done for the treated or untreated cells. Eﬀects of the
two digests on TEER across the IEC-6 cell monolayers are shown
in Fig. 4. Regarding the acrylamide-treated cells alone, the two
digests caused clear and sustained TEER value increases in the
cells at each time point. Furthermore, prolonged treatment
time led to increased TEER values. TEER values peaked at 48 h
with the two digests at 25 mg mL1, with 126.9% (CN digest) and
124.4% (GCN digest) gain with respect to the TEER value using
acrylamide only. Moreover, the CN digest was better than theThis journal is © The Royal Society of Chemistry 2018
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View Article OnlineGCN digest to increase TEER values of the cells, resulting in
much improved barrier function.
Using the FD-4 diﬀusion assay, destruction of TJs in
epithelial layer will result in increased paracellular permeability
and enhanced FD-4 transport from the apical to basolateral
wells, suggesting the destruction of intestinal epithelial mono-
layers. The cells treated with the two digests at each dose
concentration had reduced cumulative ux, compared with the
acrylamide-treated cells (ux value of 100%) (Fig. 5). The two
digests thus strengthened the cell monolayers via decreasing
the FITC-dextran paracellular ux. Using the CN digest and
GCN digest at 12.5–100 mg mL1 for 24 h, the respective ux
values decreased to 83.5–92.5% and 86.4–94.1%. Using these
digest doses but 48 h treatment time, respective ux values
decreased to 76.6–88.1% and 79.3–90.4%. That is, longer
treatment time led to decreased paracellular permeability (or
better barrier function). The CN digest also showed better
ability than the GCN digest to strengthen the cell monolayers,
once again, suggesting the adverse impact of the Maillard-type
caseinate glycation on preventive activity of the CN digest
against the induced intestinal barrier dysfunction.
Several chemicals or dietary components are able to protect
the induced intestinal barrier dysfunction. Lipopolysaccharide
(LPS) at 100 mg mL1 can injury the Caco-2 cells with FITC-Fig. 7 Immunoﬂuorescence staining for TJ proteins in IEC-6 cells treate
L1 acrylamide for 24 h. The nuclei were counterstained blue with DAPI. E
This journal is © The Royal Society of Chemistry 2018dextran permeability increase and TEER decrease; however,
somatostatin is able to protect the LPS-induced barrier
dysfunction.39 Resveratrol is also capable of protecting the
deoxynivalenol-induced intestinal damage via increasing TEER
value and decreasing paracellular permeability.32 If the Caco-2
cells are injured by dextran sulfate sodium (DSS), ()-epi-
gallocatechin-3-gallate, a polyphenolic component from tea,
shows ability to decrease paracellular permeability.42 The
present study shared similar results with these mentioned
studies.Gene expression and distribution of TJ proteins in the cells
The gut barrier is mostly formed by TJs, which are multi-protein
complexes that link adjacent epithelial cells near their apical
border. Six important TJ proteins in cell monolayers (ZO-1, ZO-
2, occludin, claudin-1, claudin-3, and claudin-4) were thereby
detected for their gene expression. Compared with the control
cells without acrylamide and digest treatment, the model cells
(exposed to acrylamide alone) had down-regulated mRNA
expression of these TJ proteins. Regarding the model cells,
those cells treated with the two digests for 24 and 48 h partially
reversed the acrylamide-induced down-regulation of these
proteins (Fig. 6). The two digests thus led to increased mRNAd with two digests for 24 (a) or 48 h (b) and then treated with 2.5 mmol
achmerge image shows overlap of one TJ protein. Scale bars¼ 50 mm.
RSC Adv., 2018, 8, 38036–38046 | 38043
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View Article Onlineexpression of these proteins. However, this assay also demon-
strated that the CN digest was more eﬀective than the GCN
digest to increase mRNA expression of these proteins, suggest-
ing the conducted caseinate glycation weakened initial activity
of the native caseins. LPS also can decrease the mRNA expres-
sion of occludin and ZO-1 in IEC-6 cells. However, cell treat-
ment with baicalin may restore the mRNA expression of ZO-1.43
Similarly, 1,25-dihydroxyvitamin D3 can enhance mRNA
expression of ZO-1, occludin, and claudin-1 in the DSS-injured
Caco-2 cells.44
To examine if the two digests could maintain epithelial
barrier function under the acrylamide stimulation, the distri-
bution and expression of three TJ proteins (ZO-1, occludin, and
claudin-1) in the cells were also assessed using an immuno-
uorescence method (Fig. 7), The results indicated that the
three proteins were localized in the intercellular junction and
distributed along the cell membrane, which was observed as
a honeycomb linear uorescence. The cells exposed to acryl-
amide at 2.5 mmol L1 for 24 h had markedly disrupted TJ
network, while the normal distribution of these proteins was
replaced by an aberrant pericellular location. Referring the
acrylamide-treated cells alone, the cells treated with the two
digests showed substantially increased secretion of these
proteins. Prolonged cell treatment time (48 h) led to furtherFig. 8 TJ protein expression and their change levels in IEC-6 cells treated
2.5 mmol L1 acrylamide for 24 h. *p < 0.05 compared with model grou
38044 | RSC Adv., 2018, 8, 38036–38046increased protein secretion (Fig. 7a versus Fig. 7b). The two
digests thus markedly attenuated the acrylamide-induced TJ
abnormalities, resulting in improved barrier function. Of
interest, the CN digest was roughly observed to bring more
secretion increases in ZO-1, occludin, and claudin-1, suggesting
the conducted caseinate glycation decreased this activity of the
GCN digest. In the past immunouorescence assays, LPS was
evidenced to disturb ZO-1 and occludin at the cellular borders,
and tert-butyl hydroperoxide could decrease ZO-1 and occludin
secretion in Caco-2 cells.39,45 Furthermore, the propolis extracts
rich in polyphenols could bring about improved TJ structure for
the injured Caco-2 cells.45Expression of TJ-associated proteins in the cells
Expression of ZO-1, occludin, and claudin-1 were also assessed
using the western blot assay (Fig. 8). The cells treated with the
two digests showed increased expression of these proteins,
regarding the model cells treated with acrylamide only. In brief,
the CN digest at 24 and 48 h led to increased ZO-1, occludin,
claudin-1 expression by 51.1–53.4%, 23.0–26.3%, and 64.5–
68.6%, while the GCN digest at same time point increased their
expression by 25.8–31.3%, 11.5–17.7%, and 55.1–59.9%,
respectively (p < 0.05). The CN digest was also notable for itswith two digests for 24 (a and c) or 48 h (b and d) and then treated with
p.
This journal is © The Royal Society of Chemistry 2018
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View Article Onlinehigher ability than the GCN digest to enhance the expression of
these proteins, once again, evidencing the adverse impact of the
conducted caseinate glycation on preventive eﬃcacy of
caseinate digest against the induced intestinal barrier
dysfunction.
Several dietary components are able to enhance TJ protein
expression and thereby protect the induced intestinal barrier
dysfunction. Beta-casofensin can increase occludin expression
in the indomethacin-induced intestinal lesions in rats.31 Bai-
calin can protect the LPS-induced intestinal epithelial cell
injury, via increasing claudin-3, occludin, and ZO-1 expres-
sion.43 Besides, it was also found that the oxyresveratrol-treated
Caco-2 cells gave rise to over-expressed ZO-1, occludin, and
claudin-1.35 It is thus reasonable that the two digests had
preventive eﬀects against the acrylamide-induced intestinal
barrier dysfunction via enhancing the expression of the three
important TJ proteins.
Conclusion
With these assessed indices, acrylamide was evidently able to
injury IEC-6 cells with barrier dysfunction including TEER
decrease and especially epithelial permeability increase.
However, both the CN digest and GCN digest could markedly
alleviate this induced barrier dysfunction, via partially restoring
the decreased TEER and increased epithelial permeability. The
two digests (especially the CN digest) up-regulated the expres-
sion of TJ proteins to keep TJ integrity, and thus improved
barrier function of the cells. Considering that the GCN digest
was a tryptic derivative from Maillard-type glycated caseinate,
another adverse eﬀect of the Maillard reaction on food proteins
was thus highlighted. That is, Maillard-type protein glycation
might confer protein digest with impaired preventive eﬃcacy to
restore intestinal barrier function if intestinal epithelial cells
are injured.
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